261 related articles for article (PubMed ID: 24886268)
1. Selective serotonin reuptake inhibitors and endothelial function in women.
Hantsoo L; Czarkowski KA; Child J; Howes C; Epperson CN
J Womens Health (Larchmt); 2014 Jul; 23(7):613-8. PubMed ID: 24886268
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitors for premenstrual syndrome.
Marjoribanks J; Brown J; O'Brien PM; Wyatt K
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
[TBL] [Abstract][Full Text] [Related]
3. Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.
Luisi AF; Pawasauskas JE
Pharmacotherapy; 2003 Sep; 23(9):1131-40. PubMed ID: 14524645
[TBL] [Abstract][Full Text] [Related]
4. Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial.
Jain N; Wan F; Kothari M; Adelodun A; Ware J; Sarode R; Hedayati SS
BMC Nephrol; 2019 Oct; 20(1):395. PubMed ID: 31664940
[TBL] [Abstract][Full Text] [Related]
5. Peripheral microvascular serotoninergic signaling is dysregulated in young adults with major depressive disorder.
Greaney JL; Dillon GA; Saunders EFH; Alexander LM
J Appl Physiol (1985); 2020 Jan; 128(1):100-107. PubMed ID: 31751182
[TBL] [Abstract][Full Text] [Related]
6. Selective serotonin reuptake inhibitors for premenstrual syndrome.
Brown J; O' Brien PM; Marjoribanks J; Wyatt K
Cochrane Database Syst Rev; 2009 Apr; (2):CD001396. PubMed ID: 19370564
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?
Pearlstein T
Drugs; 2002; 62(13):1869-85. PubMed ID: 12215058
[TBL] [Abstract][Full Text] [Related]
8. Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs.
Bismuth-Evenzal Y; Gonopolsky Y; Gurwitz D; Iancu I; Weizman A; Rehavi M
J Affect Disord; 2012 Jan; 136(1-2):99-103. PubMed ID: 21893349
[TBL] [Abstract][Full Text] [Related]
9. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
[TBL] [Abstract][Full Text] [Related]
10. SSRIs for premenstrual dysphoric disorder.
Drug Ther Bull; 2002 Sep; 40(9):70-2. PubMed ID: 12298224
[TBL] [Abstract][Full Text] [Related]
11. Comparison of managed care charges among patients treated with selective serotonin reuptake inhibitors for premenstrual dysphoric disorder.
Endicott J; McLaughlin TP; Grudzinski AN
J Clin Psychiatry; 2003 Dec; 64(12):1511-6. PubMed ID: 14728114
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.
Shah NR; Jones JB; Aperi J; Shemtov R; Karne A; Borenstein J
Obstet Gynecol; 2008 May; 111(5):1175-82. PubMed ID: 18448752
[TBL] [Abstract][Full Text] [Related]
13. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
Strawn JR; Mills JA; Croarkin PE
J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
[No Abstract] [Full Text] [Related]
14. [Psychiatric and psychological aspects of premenstrual syndrome].
Limosin F; Ades J
Encephale; 2001; 27(6):501-8. PubMed ID: 11865558
[TBL] [Abstract][Full Text] [Related]
15. Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.
Freeman EW; Rickels K; Sondheimer SJ; Polansky M; Xiao S
Am J Psychiatry; 2004 Feb; 161(2):343-51. PubMed ID: 14754784
[TBL] [Abstract][Full Text] [Related]
16. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
[TBL] [Abstract][Full Text] [Related]
17. Effects of selective serotonin reuptake inhibitors on thyroid function in depressed patients with primary hypothyroidism or normal thyroid function.
de Carvalho GA; Bahls SC; Boeving A; Graf H
Thyroid; 2009 Jul; 19(7):691-7. PubMed ID: 19583486
[TBL] [Abstract][Full Text] [Related]
18. Lamotrigine augmentation in premenstrual dysphoric disorder: a case report.
Sepede G; Martinotti G; Gambi F; Salerno RM; Di Giannantonio M
Clin Neuropharmacol; 2013; 36(1):31-3. PubMed ID: 23334074
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
[TBL] [Abstract][Full Text] [Related]
20. Effects of metergoline on symptoms in women with premenstrual dysphoric disorder.
Roca CA; Schmidt PJ; Smith MJ; Danaceau MA; Murphy DL; Rubinow DR
Am J Psychiatry; 2002 Nov; 159(11):1876-81. PubMed ID: 12411222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
